New 3-[4-(aryl)piperazin-1-yl]-1(benzo[b]thiophen-3-yl) propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants

被引:50
|
作者
Martínez, J
Pérez, S
Oficialdegui, AM
Heras, B
Orús, L
Villanueva, H
Palop, JA
Roca, J
Mourelle, M
Bosch, A
Del Castillo, JC
Lasheras, B
Tordera, R
del Río, J
Monge, A
机构
[1] Univ Navarra, Dept Med Chem, E-31080 Pamplona, Spain
[2] Univ Navarra, CIFA, E-31080 Pamplona, Spain
[3] Univ Navarra, Dept Pharmacol, E-31080 Pamplona, Spain
[4] Vita Invest SA, Barcelona 08970, Spain
关键词
arylpiperazines; antidepressant; 5-HT1A antagonist; serotonin reuptake inhibitor;
D O I
10.1016/S0223-5234(00)01198-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of new 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives were synthesized in an attempt to find a new class of antidepressant drugs with dual activity at 5-HT1A serotonin receptors and serotonin transporter. Title compounds were evaluated for in vitro activity on 5-HT1A receptor and 5-HT transporter. They show high nanomolar affinity for both activities, and in particular, compounds 1-(5-chlorobenzo[b]thiophen-3-yl)-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-1-ol (7) and 1-(5-fluorobenzo[b]thiophen-3-yl)-3-[4-(2-methoxyphenyl) piperain-1-yl]propan-1-ol (8) show values (nM) of K-i = 30 and 2.3 for 5-HT1A receptors and K-i = 30 and 12 for serotonin transporters, respectively. In GTP gammaS binding assays, compound 8 revealed antagonist properties to 5-HT1A receptors. Such a pharmacological profile could lead to potent antidepressant agents with new dual mechanism of action. (C) 2001 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 25 条
  • [21] The anti-epileptogenic and cognition enhancing effect of novel 1-[4-(4-benzo [1, 3] dioxol-5-ylmethyl-piperazin-1-yl)-phenyl]-3-phenyl-urea (BPPU) in pentylenetetrazole induced chronic rat model of epilepsy
    Mishra, Chandra Bhushan
    Kumari, Shikha
    Siraj, Fouzia
    Yadav, Rajesh
    Kumari, Sweta
    Tiwari, Ankit Kumar
    Tiwari, Manisha
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 105 : 470 - 480
  • [22] 6-[2-(4-aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones:: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors
    Bromidge, Steven M.
    Bertani, Barbara
    Borriello, Manuela
    Faedo, Stefania
    Gordon, Laurie J.
    Granci, Enrica
    Hill, Matthew
    Marshall, Howard R.
    Stasi, Luigi P.
    Zucchelli, Valeria
    Merlo, Giancarlo
    Vesentini, Alessia
    Watson, Jeannette M.
    Zonzini, Laura
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) : 5653 - 5656
  • [23] 8-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: Dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors-Part II
    Bromidge, Steven M.
    Bertani, Barbara
    Borriello, Manuela
    Bozzoli, Andrea
    Faedo, Stefania
    Gianotti, Massimo
    Gordon, Laurie J.
    Hill, Matthew
    Zucchelli, Valeria
    Watson, Jeannette M.
    Zonzini, Laura
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (08) : 2338 - 2342
  • [24] Biologically active 1-arylpiperazines.: Synthesis of new N-(4-aryl-1-piperazinyl)alkyl derivatives of quinazolidin-4(3H)-one, 2,3-dihydrophthalazine-1,4-dione and 1,2-dihydropyridazine-3,6-dione as potential serotonin receptor ligands
    Kowalski, P
    Kowalska, T
    Mokrosz, MJ
    Bojarski, AJ
    Charakchieva-Minol, S
    MOLECULES, 2001, 6 (09) : 784 - 795
  • [25] Identification and Development of a New Positron Emission Tomography Ligand 4-(2-Fluoro-4-[11C]methoxyphenyl)-5-((1-methyl-1H-pyrazol-3-yl)methoxy)picolinamide for Imaging Metabotropic Glutamate Receptor Subtype 2 (mGlu2)
    Yamasaki, Tomoteru
    Zhang, Xiaofei
    Kumata, Katsushi
    Zhang, Yiding
    Deng, Xiaoyun
    Fujinaga, Masayuki
    Chen, Zhen
    Mori, Wakana
    Hu, Kuan
    Wakizaka, Hidekatsu
    Hatori, Akiko
    Xie, Lin
    Ogawa, Masanao
    Nengaki, Nobuki
    Van, Richard
    Shao, Yihan
    Sheffler, Douglas J.
    Cosford, Nicholas D. P.
    Liang, Steven H.
    Zhang, Ming-Rong
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (20) : 11469 - 11483